Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$10.93 -0.59 (-5.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Non Operating Income (2025 - 2026)

Updated

Corvus Pharmaceuticals (CRVS) recorded Non Operating Income of $1.34 million in Q2 2026, down 40.8% from $2.26 million a year earlier but up 12.9% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Non Operating Income (2025 - 2026) Analysis & Trends

On a TTM basis, Corvus Pharmaceuticals' Non Operating Income came in at $29.9 million as of Jun 30, 2026.

  • Quarterly Non Operating Income has ranged from $1.19 million in Q1 2026 to $25.12 million in Q1 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Corvus Pharmaceuticals 969.07 Mn 457.51 Mn - 1.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.34 Mn
Mar 31, 2026 1.19 Mn
Jun 30, 2025 2.26 Mn
Mar 31, 2025 25.12 Mn
API Access

Corvus Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRVS&period=max&api_key=YOUR_API_KEY